Overview of Guarantee Situation
- On February 3, 2026, Prolo Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") signed an "Irrevocable Guarantee Letter" (Contract No.: 571HT260202T00092801) with China Merchants Bank Jinhua Yiwu Branch ("China Merchants Bank"), agreeing to provide a joint liability guarantee for a working capital loan of 20 million yuan for its wholly-owned subsidiary, Zhejiang Prolo Jiayuan Pharmaceutical Co., Ltd. (hereinafter referred to as "Jiayuan Pharmaceutical"). The guarantee period is 12 months.
- On February 4, 2026, the Company signed another "Irrevocable Guarantee Letter" (Contract No.: 571HT260203T00179801) with China Merchants Bank, agreeing to provide a joint liability guarantee for a working capital loan of 10 million yuan for Jiayuan Pharmaceutical. The guarantee period is also 12 months.
Review Procedures for Guarantee Matters
The Company held the 11th meeting of the 9th Board of Directors on March 7, 2025, and the 2024 Annual General Meeting on April 17, 2025, where it approved the proposal regarding the expected guarantees for subsidiaries, providing financing guarantees of up to 7.1 billion yuan for 10 subsidiaries and sub-subsidiaries from banks and other financial institutions. The authorization period for this external guarantee limit is from the date of approval at the 2024 Annual General Meeting until the date of the 2025 Annual General Meeting. For specific details, please refer to the announcements disclosed by the Company on March 11, 2025, and April 18, 2025, in the Securities Times and the Giant Tide Information Network.